Medication

CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has…

The UK Health Security Agency (UKHSA) has issued red heat health warnings as temperatures soar People who take…

WHITESBORO, N.Y — Starting next Wednesday, eligible Medicare patients will be able to enroll in the new Medicare…

Historical FDA investigator badges at the agency’s headquarters in Silver Spring, MD. (credit: Ferdous Al-Faruque)…

Share on PinterestAn estimated 14 million Medicare Part D recipients could obtain Wegovy, Foundayo, and Zepbound for $50…

For years, topical minoxidil has been the gold-standard treatment for hair growth. So it’s no surprise that its…

Weight loss medication entering into the mainstream could fundamentally reshape how millions of people shop and what retailers…

CLEVELAND — A Cleveland-led team from University Hospitals, Case Western Reserve University and the Louis Stokes VA has identified…

Pharmac has announced it will fund another brand of methylphenidate from October, in order to help improve supply…

The FDA approved oral Wegovy (semaglutide) on December 22, 2025. Eli Lilly received approval for its pill, Foundayo…

WOODSTOCK, New York (WABC) — It’s hard enough for anyone to deal with debilitating arthritis. But Jim Rice…

The petitioners contended that they serve public interest by offering medicines at reduced prices, foregoing a portion of…

TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)